ANI Pharmaceuticals reported $22.83M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Novartis USD 4.48B 343M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025